Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Cervical Cancer

  Free Subscription


14.10.2019

1 ACS Appl Mater Interfaces
1 Acta Radiol
1 Am J Obstet Gynecol
1 Analyst
1 Arch Virol
1 Asian Pac J Allergy Immunol
1 Biochem Biophys Res Commun
1 BMJ Open
1 Br J Gen Pract
1 Cancer Causes Control
1 Cancer Cytopathol
1 Cancer Epidemiol
1 Cancer Radiother
1 Carcinogenesis
1 Cas Lek Cesk
1 Cell Cycle
1 Clin Exp Pharmacol Physiol
1 Eur J Epidemiol
1 Gulf J Oncolog
1 Int J Biol Sci
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
1 J Acquir Immune Defic Syndr
1 J Cancer
1 J Cancer Res Clin Oncol
1 J Emerg Med
2 J Low Genit Tract Dis
1 J Magn Reson Imaging
1 J Natl Cancer Inst
1 Life Sci
1 Medicine (Baltimore)
1 Obstet Gynecol
1 Oncology
1 Open Access Maced J Med Sci
1 Pan Afr Med J
1 PLoS One
1 Porto Biomed J
1 Public Health
1 Radiat Oncol
1 Rev Saude Publica
1 Support Care Cancer
1 Surg Neurol Int
1 Virol J
1 Yakugaku Zasshi
1 Zhonghua Yi Xue Yi Chuan Xue Za Zhi
1 Zhonghua Yu Fang Yi Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    ACS Appl Mater Interfaces

  1. HU X, Mandika C, He L, You Y, et al
    Construction of Urokinase Type Plasminogen Activator Receptor (uPAR)-Targeted Heterostructures for Efficient Photothermal-Chemotherapy against Cervical Cancer to Achieve Simultaneous Anticancer and Antiangiogenesis.
    ACS Appl Mater Interfaces. 2019 Oct 7. doi: 10.1021/acsami.9b15751.
    PubMed     Text format     Abstract available


    Acta Radiol

  2. ZHOU G, Chen X, Shen R, Xu J, et al
    Apparent diffusion coefficients are closely related with high-risk human papilloma virus infection in cervical squamous cell carcinoma patients.
    Acta Radiol. 2019;60:1372-1379.
    PubMed     Text format    


    Am J Obstet Gynecol

  3. OBERMAIR A, Asher R, Pareja R, Frumovitz M, et al
    Incidence of adverse events in minimally invasive versus open radical hysterectomy in early cervical cancer: Results of a randomized controlled trial.
    Am J Obstet Gynecol. 2019 Oct 3. pii: S0002-9378(19)31165.
    PubMed     Text format     Abstract available


    Analyst

  4. XIAO HM, Wang X, Liao QL, Zhao S, et al
    Sensitive analysis of multiple low-molecular-weight thiols in a single human cervical cancer cell by chemical derivatization-liquid chromatography-mass spectrometry.
    Analyst. 2019 Oct 9. doi: 10.1039/c9an01566.
    PubMed     Text format     Abstract available


    Arch Virol

  5. MOON JH, Jeong K, Kim K, Lee C, et al
    Comparison of clinical performance of two high-throughput liquid bead microarray assays, GeneFinder and CareGENE, for cervical screening in the general population.
    Arch Virol. 2019;164:2699-2706.
    PubMed     Text format     Abstract available


    Asian Pac J Allergy Immunol

  6. LOHARAMTAWEETHONG K, Supakatitham C, Vinyuvat S, Puripat N, et al
    Prognostic significance of PD-L1 protein expression and copy number gains in locally advanced cervical cancer.
    Asian Pac J Allergy Immunol. 2019 Oct 6. doi: 10.12932/AP-120419-0538.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  7. NAKAMURA Y, Nakahata S, Kondo Y, Izumi A, et al
    Overexpression of absent in melanoma 2 in oral squamous cell carcinoma contributes to tumor progression.
    Biochem Biophys Res Commun. 2018 Dec 23. pii: S0006-291X(18)32709.
    PubMed     Text format     Abstract available


    BMJ Open

  8. WANG Y, Ouyang Y, Su J, Liu J, et al
    Multicentre, randomised controlled trial of adjuvant chemotherapy in cervical cancer with residual human papilloma virus DNA following primary radiotherapy or chemoradiotherapy: a study protocol.
    BMJ Open. 2019;9:e028171.
    PubMed     Text format     Abstract available


    Br J Gen Pract

  9. CAROE TD
    High results.
    Br J Gen Pract. 2019;69:490.
    PubMed     Text format    


    Cancer Causes Control

  10. KHUSHALANI JS, Trogdon JG, Ekwueme DU, Yabroff KR, et al
    Economics of public health programs for underserved populations: a review of economic analysis of the National Breast and Cervical Cancer Early Detection Program.
    Cancer Causes Control. 2019 Oct 9. pii: 10.1007/s10552-019-01235.
    PubMed     Text format     Abstract available


    Cancer Cytopathol

  11. GE Y, Christensen PA, Luna E, Armylagos D, et al
    Age-specific 3-year cumulative risk of cervical cancer and high-grade dysplasia on biopsy in 9434 women who underwent HPV cytology cotesting.
    Cancer Cytopathol. 2019 Oct 7. doi: 10.1002/cncy.22192.
    PubMed     Text format     Abstract available


    Cancer Epidemiol

  12. PARKIN DM
    Population risk factors for late-stage presentation of cervical cancer in sub-Saharan Africa. Stewart et al Cancer Epidemiol. 2018 Apr; 53:81-92.
    Cancer Epidemiol. 2019 Oct 4:101599. doi: 10.1016/j.canep.2019.101599.
    PubMed     Text format    


    Cancer Radiother

  13. BRIENS A, Castelli J, Barateau A, Jaksic N, et al
    [Adaptive radiotherapy: Strategies and benefits depending on tumor localization].
    Cancer Radiother. 2019;23.
    PubMed     Text format     Abstract available


    Carcinogenesis

  14. JUNG J, Kim S, An HT, Ko J, et al
    alpha-Actinin-4 regulates cancer stem cell properties and chemoresistance in cervical cancer.
    Carcinogenesis. 2019 Oct 4. pii: 5581248. doi: 10.1093.
    PubMed     Text format     Abstract available


    Cas Lek Cesk

  15. NGO O, Chloupkova R, Ambrozova M, Suchanek S, et al
    Evaluation of the personalized invitation of Czech citizens to screening programs.
    Cas Lek Cesk. 2019;158.
    PubMed     Text format     Abstract available


    Cell Cycle

  16. LI H, Hong J, Wijayakulathilaka WSMA
    Long non-coding RNA SNHG4 promotes cervical cancer progression through regulating c-Met via targeting miR-148a-3p.
    Cell Cycle. 2019 Oct 7:1-12. doi: 10.1080/15384101.2019.1674071.
    PubMed     Text format     Abstract available


    Clin Exp Pharmacol Physiol

  17. TONG R, Zhang J, Wang C, Li X, et al
    LncRNA PTCSC3 inhibits the proliferation, invasion and migration of cervical cancer cells via sponging miR-574-5p.
    Clin Exp Pharmacol Physiol. 2019 Oct 6. doi: 10.1111/1440-1681.13186.
    PubMed     Text format     Abstract available


    Eur J Epidemiol

  18. LI X, Yu C, Guo Y, Bian Z, et al
    Association between tea consumption and risk of cancer: a prospective cohort study of 0.5 million Chinese adults.
    Eur J Epidemiol. 2019;34:753-763.
    PubMed     Text format     Abstract available


    Gulf J Oncolog

  19. ALKHALAWI E, Al-Madouj A, Al-Zahrani A
    Cervical Cancer Incidence and Trends among Nationals of the Gulf Cooperation Council States, 1998-2012.
    Gulf J Oncolog. 2019;1:7-13.
    PubMed     Text format     Abstract available


    Int J Biol Sci

  20. LI H, Chi X, Li R, Ouyang J, et al
    HIV-1-infected cell-derived exosomes promote the growth and progression of cervical cancer.
    Int J Biol Sci. 2019;15:2438-2447.
    PubMed     Text format     Abstract available


    Int J Cancer

  21. SULTANA F, Winch K, Saville M, Brotherton JM, et al
    Is the positive predictive value of high-grade cytology in predicting high-grade cervical disease falling due to HPV vaccination?
    Int J Cancer. 2018 Dec 10. doi: 10.1002/ijc.32050.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  22. LIN AJ, Kidd E, Dehdashti F, Siegel BA, et al
    Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer.
    Int J Radiat Oncol Biol Phys. 2019;103:1088-1097.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  23. COLIE C, Michel KG, Massad LS, Wang MC, et al
    Natural history of cervical intraepithelial neoplasia-2 in HIV-positive women of reproductive age.
    J Acquir Immune Defic Syndr. 2018 Sep 21. doi: 10.1097/QAI.0000000000001865.
    PubMed     Text format     Abstract available


    J Cancer

  24. YAN Z, Zhou Z, Li C, Yang X, et al
    Polymorphisms in miRNA genes play roles in the initiation and development of cervical cancer.
    J Cancer. 2019;10:4747-4753.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  25. HORN LC, Handzel R, Borte G, Siebolts U, et al
    Invasive stratified mucin-producing carcinoma (i-SMILE) of the uterine cervix: report of a case series and review of the literature indicating poor prognostic subtype of cervical adenocarcinoma.
    J Cancer Res Clin Oncol. 2019;145:2573-2582.
    PubMed     Text format     Abstract available


    J Emerg Med

  26. ADLER D, Abar B, Wood N, Bonham A, et al
    An Intervention to Increase Uptake of Cervical Cancer Screening Among Emergency Department Patients: Results of a Randomized Pilot Study.
    J Emerg Med. 2019 Oct 5. pii: S0736-4679(19)30650.
    PubMed     Text format     Abstract available


    J Low Genit Tract Dis

  27. TEOH D, Vogel RI, Langer A, Bharucha J, et al
    Effect of an Electronic Health Record Decision Support Alert to Decrease Excess Cervical Cancer Screening.
    J Low Genit Tract Dis. 2019;23:253-258.
    PubMed     Text format     Abstract available

  28. SIEGLER E, Reichman Y, Kugelman N, Mackuli L, et al
    Low-Risk Human Papillomavirus Types in Cervical Intraepithelial Neoplasia 2-3 and in Invasive Cervical Cancer Patients.
    J Low Genit Tract Dis. 2019;23:248-252.
    PubMed     Text format     Abstract available


    J Magn Reson Imaging

  29. SONG J, Hu Q, Huang J, Ma Z, et al
    Multicystic mucinous adenocarcinoma of the uterine cervix compared with benign multicystic lesions: Multiparametric MR features.
    J Magn Reson Imaging. 2018 Apr 6. doi: 10.1002/jmri.26038.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  30. YU K, Hyun N, Fetterman B, Lorey T, et al
    Automated Cervical Screening and Triage, Based on HPV Testing and Computer-Interpreted Cytology.
    J Natl Cancer Inst. 2018 Apr 11. pii: 4961333. doi: 10.1093.
    PubMed     Text format     Abstract available


    Life Sci

  31. VARGHESE VK, Shukla V, Jishnu PV, Kabekkodu SP, et al
    Characterizing methylation regulated miRNA in carcinoma of the human uterine cervix.
    Life Sci. 2019;232:116668.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  32. YUAN M, Yao L, Abulizi G
    Tumor-suppressor gene SOX1 is a methylation-specific expression gene in cervical adenocarcinoma.
    Medicine (Baltimore). 2019;98:e17225.
    PubMed     Text format     Abstract available


    Obstet Gynecol

  33. QUINLAN MP, Quinlan JJ
    Mozart for Reducing Patient Anxiety During Colposcopy: A Randomized Controlled Trial.
    Obstet Gynecol. 2019;133:191.
    PubMed     Text format    


    Oncology

  34. DE GREGORIO A, Widschwendter P, Ebner F, Friedl TWP, et al
    Influence of the New FIGO Classification for Cervical Cancer on Patient Survival: A Retrospective Analysis of 265 Histologically Confirmed Cases with FIGO Stages IA to IIB.
    Oncology. 2019 Oct 8:1-7. doi: 10.1159/000503149.
    PubMed     Text format     Abstract available


    Open Access Maced J Med Sci

  35. AJAYI MP, Amoo EO, Olawande TI, Iruonagbe TC, et al
    Awareness of Breast and Cervical Cancer among Women in the Informal Sector in Nigeria.
    Open Access Maced J Med Sci. 2019;7:2371-2376.
    PubMed     Text format     Abstract available


    Pan Afr Med J

  36. KEMO ADD, Nkegoum B, Nangue C, Djuikwo F, et al
    Histo-epidemiological aspects of gynecological and breast cancers at the University Teaching Hospital of Yaounde.
    Pan Afr Med J. 2019;33:130.
    PubMed     Text format     Abstract available


    PLoS One

  37. MAHUMUD RA, Alam K, Dunn J, Gow J, et al
    The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia.
    PLoS One. 2019;14:e0223658.
    PubMed     Text format     Abstract available


    Porto Biomed J

  38. TEIXEIRA C, Afonso A, Rodrigues L, Madureira M, et al
    Incidence and mortality due to cervical cancer in 4 south European countries.
    Porto Biomed J. 2018;4:e26.
    PubMed     Text format     Abstract available


    Public Health

  39. CHAN DNS, So WKW
    The impact of community-based multimedia intervention on the new and repeated cervical cancer screening participation among South Asian women.
    Public Health. 2019;178:1-4.
    PubMed     Text format     Abstract available


    Radiat Oncol

  40. FEDERICO M, Hernandez-Socorro CR, Ribeiro I, Martin JG, et al
    Prospective intra/inter-observer evaluation of pre-brachytherapy cervical cancer tumor width measured in TRUS and MR imaging.
    Radiat Oncol. 2019;14:173.
    PubMed     Text format     Abstract available


    Rev Saude Publica

  41. ROZARIO SD, Silva IFD, Koifman RJ, Silva IFD, et al
    Characterization of women with cervical cancer assisted at Inca by histological type.
    Rev Saude Publica. 2019;53:88.
    PubMed     Text format     Abstract available


    Support Care Cancer

  42. OSANN K, Wilford J, Wenzel L, Hsieh S, et al
    Relationship between social support, quality of life, and Th2 cytokines in a biobehavioral cancer survivorship trial.
    Support Care Cancer. 2019;27:3301-3310.
    PubMed     Text format     Abstract available


    Surg Neurol Int

  43. TAKAYANAGI A, Florence TJ, Hariri OR, Armstrong A, et al
    Brain metastases from cervical cancer reduce longevity independent of overall tumor burden.
    Surg Neurol Int. 2019;10:176.
    PubMed     Text format     Abstract available


    Virol J

  44. FARZANEHPOUR M, Mozhgani SH, Jalilvand S, Faghihloo E, et al
    Serum and tissue miRNAs: potential biomarkers for the diagnosis of cervical cancer.
    Virol J. 2019;16:116.
    PubMed     Text format     Abstract available


    Yakugaku Zasshi

  45. TAKAGI M, Sagara A, Ishizawa A, Ito A, et al
    [Effects of Renal Function Evaluation with or without Serum Creatinine Adjustment on Cisplatin/Fluorouracil Therapy for Cervical Cancer].
    Yakugaku Zasshi. 2019;139:1327-1332.
    PubMed     Text format     Abstract available


    Zhonghua Yi Xue Yi Chuan Xue Za Zhi

  46. ZHEN J, Zhu L, Li W, Hu H, et al
    [A protective effect conferred by KIR3DL1 and its cognate ligand against cervical cancer among ethnic Han Chinese population and its potential mechanism].
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2019;36:1035-1038.
    PubMed     Text format     Abstract available


    Zhonghua Yu Fang Yi Xue Za Zhi


  47. [Expert consensus on immunological prevention of human papillomavirus-related diseases].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2019;53:761-803.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: